Postnatal growth responses to insulin-like growth factor I in insulin receptor substrate-1-deficient mice

Endocrinology

Volumn 140, Issue 12, 1999, Pages 5478-5487

  Pete, Gina ^a   Fuller, C Randall ^b   Oldham, Jenny M ^c   Smith, Dani R ^a   D'Ercole, A Joseph ^b   Kahn, C Ronald ^d   Lund, P Kay ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c RUAKURA RESEARCH CENTRE   (New Zealand)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; SOMATOMEDIN C;

ANIMAL TISSUE; ARTICLE; BODY WEIGHT; FEMALE; GASTROCNEMIUS MUSCLE; GENE OVEREXPRESSION; GROWTH RETARDATION; HEART WEIGHT; HORMONE ACTION; HORMONE RESPONSE; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; POSTNATAL GROWTH; PRIORITY JOURNAL; SPLEEN WEIGHT;

EID: 0033305504     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.12.7219     Document Type: Article

References (30)

1. Normal and aberrant growth
2. Growth enhancement of transgenic mice expressing human insulin-like growth factor I
3. Use of transgenic mice for understanding the physiology of insulin-like growth factors
4. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I
5. Signaling via the insulin-like growth factor-I receptor does it differ from insulin receptor signaling?
6. The insulin signaling system and the IRS proteins
7. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-I gene
8. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
9. Insulin signaling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice
10. Growth hormone, interferon-γ, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1
11. Induction of immunoreactive somatomedin-C in human serum by growth hormone: Dose response relationships and effect on chromatographic profiles
12. Evidence that somatomedin is synthesized by multiple tissues in fetus
13. Somatomedin-C/insulin growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues
14. Regulation and localization of the insulin-like growth factor System in small bowel during altered nutrient status
15. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type 1 IGF receptor (IGF1R)
16. IGF-I is required for normal embryonic growth in mice
17. IGF-I gene disruption results in reduced brain size, CNS hypomyelination and loss of hippocampal and striatal parvalbumin-containing neurons
18. Enhancement of insulin-like growth factor Signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo
19. Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-I receptor and insulin receptor substrate-1 in the uterus
20. Insulin-like growth factor binding proteins
21. IGFs and skeletal muscle
22. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice
23. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1 deficient cells
24. Role of IRS-2 in insulin and cytokine signaling
25. Insulin receptor substrate 1 antisense expression in an hepatoma cell line reduces cell proliferation and induces overexpression of the Src homology 2 domain and collagen protein (SHC)
26. Enhancement or inhibition of insulin signaling by insulin receptor substrate 1 is cell context dependent
27. Role of growth factors and cytokines in hepatic regeneration
28. Insulin-like growth factor I receptors in adult rat liver: Characterization and in vivo regulation
29. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice
30. Insulin-like growth factors: Gene and mRNA structure and regulation